Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

The Best Dividend ETF to Invest $500 in Right Nowfool.com
Via The Motley Fool · May 14, 2025
Palantir Stock Investors: You Need to See Thisfool.com
Via The Motley Fool · May 14, 2025
Why Is NU Stock Down After Earnings and Should Investors Be Concerned?fool.com
Via The Motley Fool · May 14, 2025
Recent Trade Deal Updates Bring Amazing News to Nvidia Stock Investorsfool.com
Via The Motley Fool · May 14, 2025
Why Nvidia Stock Continues to Soarfool.com
Via The Motley Fool · May 14, 2025
Mayhem Continuestalkmarkets.com
A 90-day pause on embargo-style US-China trade tariffs has revived bullish spirits.
Via Talk Markets · May 14, 2025
Dollar Unwinds More Of Monday's Surgetalkmarkets.com
The US dollar is extending yesterday's pullback after Monday's sharp rally.
Via Talk Markets · May 14, 2025
Huge News for Amazon Stock Investorsfool.com
Via The Motley Fool · May 14, 2025
What Did You Do During The April Stock Market Crash?talkmarkets.com
President Trump’s “Liberation Day” announcement of imposing significant tariffs on the rest of the world triggered a steep and scary sell-off in the stock market.
Via Talk Markets · May 14, 2025
XRP Up 416% Over The Past Year: How High Can It Go?benzinga.com
XRP (CRYPTO: XRP) has surged 416% over the past year, with recent market data pointing to a strong undercurrent of accumulation despite heightened speculation.
Via Benzinga · May 14, 2025
'I Thought He Wanted To Be A Drug Dealer,' How Cannabis Healed A Father-Son Rift And Sparked Two Thriving Businessesbenzinga.com
After cannabis healed their rift, Los Arias and his father launched Flostar Group. Now he's speaking at Benzinga's June conference.
Via Benzinga · May 14, 2025
Novo Nordisk Inks $2.2 Billion Deal With Septerna To Develop Oral Weight Loss And Diabetes Drugsbenzinga.com
Novo Nordisk and Septerna enter $2.2 billion deal to develop oral small-molecule therapies targeting obesity, diabetes, and cardiometabolic diseases.
Via Benzinga · May 14, 2025
Cisco Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Callbenzinga.com
Via Benzinga · May 14, 2025
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earningsbenzinga.com
Via Benzinga · May 14, 2025
Zijin Mining Seeks Hong Kong IPO For Offshore Assetsbenzinga.com
Zijin Mining plans to spin off its offshore gold assets in a Hong Kong IPO.
Via Benzinga · May 14, 2025
These Analysts Slash Their Forecasts On UnitedHealthbenzinga.com
Via Benzinga · May 14, 2025
Ford Recalls Nearly 274,000 SUVs In US: Retail Gets More Bearishstocktwits.com
The recall covers model years 2022 to 2024 of the Lincoln Navigator and Ford Expedition vehicles.
Via Stocktwits · May 14, 2025
This Hong Kong IPO Candidate May Benefit From Policy Tailwindsbenzinga.com
This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.
Via Benzinga · May 14, 2025
Super Micro Computer Stock Is Surging Again: What's Going On?benzinga.com
Super Micro Computer Inc (NASDAQ:SMCI) shares are soaring again Wednesday after rising 16% on Tuesday. Here's a look at what's going on.
Via Benzinga · May 14, 2025
QCOM Q1 Earnings Call: AI, Automotive, and IoT Drive Revenue Above Expectations
Wireless chipmaker Qualcomm (NASDAQ:QCOM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.9% year on year to $10.98 billion. The company expects next quarter’s revenue to be around $10.3 billion, close to analysts’ estimates. Its non-GAAP profit of $2.85 per share was 1% above analysts’ consensus estimates.
Via StockStory · May 14, 2025
GSK To Buy Phase-3 Ready Liver Disease Drug For Up To $2 Billionbenzinga.com
GSK acquires Boston Pharmaceuticals' efimosfermin for up to $2 billion, targeting liver diseases like MASH and ALD.
Via Benzinga · May 14, 2025
Earnings Beating Expectationstalkmarkets.com
Q1 Earnings are much better than expected.
Via Talk Markets · May 14, 2025
ITW Q1 Earnings Call: Tariff Mitigation and Steady Execution Amid Uncertain Demand
Manufacturing company Illinois Tool Works (NYSE:ITW) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.4% year on year to $3.84 billion. Its GAAP profit of $2.38 per share was 1% above analysts’ consensus estimates.
Via StockStory · May 14, 2025
Dynatrace Stock Rises On Upbeat Q4 Earnings, Retail Turns Extremely Bullishstocktwits.com
The company’s revenue rose 17%, with subscription revenue improving 18% and operating margin expanding to 10%.
Via Stocktwits · May 14, 2025
On Holding Analysts Raise Their Forecasts After Upbeat Resultsbenzinga.com
Via Benzinga · May 14, 2025